245 related articles for article (PubMed ID: 34506728)
21. Clinical and biochemical aspects of carnitine deficiency and insufficiency: transport defects and inborn errors of beta-oxidation.
Angelini C; Vergani L; Martinuzzi A
Crit Rev Clin Lab Sci; 1992; 29(3-4):217-42. PubMed ID: 1489518
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
23. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
Calvani M; Reda E; Arrigoni-Martelli E
Basic Res Cardiol; 2000 Apr; 95(2):75-83. PubMed ID: 10826498
[TBL] [Abstract][Full Text] [Related]
24. On the interrelationship between hepatic carnitine, fatty acid oxidation, and triglyceride biosynthesis in nephrosis.
al-Shurbaji A; Berglund L; Berge RK; Cederblad G; Humble E
Lipids; 1997 Aug; 32(8):847-52. PubMed ID: 9270976
[TBL] [Abstract][Full Text] [Related]
25. Primary and secondary carnitine deficiency syndromes.
Pons R; De Vivo DC
J Child Neurol; 1995 Nov; 10 Suppl 2():S8-24. PubMed ID: 8576570
[TBL] [Abstract][Full Text] [Related]
26. Participation of peroxisomes in the metabolism of xenobiotic acyl compounds: comparison between peroxisomal and mitochondrial beta-oxidation of omega-phenyl fatty acids in rat liver.
Yamada J; Ogawa S; Horie S; Watanabe T; Suga T
Biochim Biophys Acta; 1987 Sep; 921(2):292-301. PubMed ID: 3651489
[TBL] [Abstract][Full Text] [Related]
27. Effects of carnitine on fatty-acid oxidation by muscle.
FRITZ IB; McEWEN B
Science; 1959 Feb; 129(3345):334-5. PubMed ID: 13624727
[No Abstract] [Full Text] [Related]
28. Mitochondrial fatty acid beta-oxidation in the human eye and brain: implications for the retinopathy of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.
Tyni T; Paetau A; Strauss AW; Middleton B; Kivelä T
Pediatr Res; 2004 Nov; 56(5):744-50. PubMed ID: 15347768
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids.
Yuasa M; Hata I; Sugihara K; Isozaki Y; Ohshima Y; Hara K; Tajima G; Shigematsu Y
Dis Markers; 2019; 2019():2984747. PubMed ID: 30881520
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial and peroxisomal fatty acid oxidation in elasmobranchs.
Moyes CD; Buck LT; Hochachka PW
Am J Physiol; 1990 Mar; 258(3 Pt 2):R756-62. PubMed ID: 2316720
[TBL] [Abstract][Full Text] [Related]
31. Specificity of carnitine action on fatty acid oxidation by heart muscle.
FRITZ IB; KAPLAN E; YUE KT
Am J Physiol; 1962 Jan; 202():117-21. PubMed ID: 13895427
[No Abstract] [Full Text] [Related]
32. L-carnitine is essential to beta-oxidation of quarried fatty acid from mitochondrial membrane by PLA(2).
Yano H; Oyanagi E; Kato Y; Samejima Y; Sasaki J; Utsumi K
Mol Cell Biochem; 2010 Sep; 342(1-2):95-100. PubMed ID: 20443048
[TBL] [Abstract][Full Text] [Related]
33. TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes.
Miklas JW; Clark E; Levy S; Detraux D; Leonard A; Beussman K; Showalter MR; Smith AT; Hofsteen P; Yang X; Macadangdang J; Manninen T; Raftery D; Madan A; Suomalainen A; Kim DH; Murry CE; Fiehn O; Sniadecki NJ; Wang Y; Ruohola-Baker H
Nat Commun; 2019 Oct; 10(1):4671. PubMed ID: 31604922
[TBL] [Abstract][Full Text] [Related]
34.
Tan X; Zhu T; Zhang L; Fu L; Hu Y; Li H; Li C; Zhang J; Liang B; Liu J
Adipocyte; 2022 Dec; 11(1):120-132. PubMed ID: 35094659
[TBL] [Abstract][Full Text] [Related]
35. Effect of methylglyoxal bis(guanylhydrazone) on hepatic, heart and skeletal muscle mitochondrial carnitine palmitoyltransferase and beta-oxidation of fatty acids.
Brady LJ; Brady PS; Gandour RD
Biochem Pharmacol; 1987 Feb; 36(4):447-52. PubMed ID: 3827937
[TBL] [Abstract][Full Text] [Related]
36. Defects of fatty-acid oxidation in muscle.
Angelini C
Baillieres Clin Endocrinol Metab; 1990 Sep; 4(3):561-82. PubMed ID: 2268228
[TBL] [Abstract][Full Text] [Related]
37. Mouse models for disorders of mitochondrial fatty acid beta-oxidation.
Schuler AM; Wood PA
ILAR J; 2002; 43(2):57-65. PubMed ID: 11917157
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation.
Kler RS; Jackson S; Bartlett K; Bindoff LA; Eaton S; Pourfarzam M; Frerman FE; Goodman SI; Watmough NJ; Turnbull DM
J Biol Chem; 1991 Dec; 266(34):22932-8. PubMed ID: 1744086
[TBL] [Abstract][Full Text] [Related]
39. Development of oxaalkyne and alkyne fatty acids as novel tracers to study fatty acid beta-oxidation pathways and intermediates.
Kuerschner L; Leyendecker P; Klizaite K; Fiedler M; Saam J; Thiele C
J Lipid Res; 2022 Apr; 63(4):100188. PubMed ID: 35247455
[TBL] [Abstract][Full Text] [Related]
40. Knockout of Tmlhe in mice is not associated with autism spectrum disorder phenotypes or motor dysfunction despite low carnitine levels.
Liepinsh E; Svalbe B; Stelfa G; Grinberga S; Zvejniece L; Schiöth HB; Dambrova M
Mol Autism; 2023 Aug; 14(1):29. PubMed ID: 37553674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
